Medical and Health Sciences/Health biotechnology

You are here

01 Jun 2020
WG

Raising FAIRness in health data and health research performing organisations (HRPOs) WG

Status: 
Recognised & Endorsed

Adoption and application of the FAIR principles to research data has grown significantly in the few years that they have existed. They have been embraced in many quarters and have paved the way to creating a level playing field for data reuse. Nevertheless, they also pose challenges in some areas of research where reuse may not be an automatic right due to issues of confidentiality, privacy, commercial interests and sensitivities in general.

continue reading

26 Feb 2020
HG

Synthetic (micro)biology, biosafety and biosecurity: policy compliance - ABS Regulation, CBD, The Nagoya & Kuala Lumpur, and Cartagena Protocols

Status: 
Withdrawn
Chair (s): 

 

    TOPICS:

1. Synthetic (micro)biology, biosafety and biosecurity

2. Biotechnology and bioeconomy: sustainable goals, circular economy, "zero pollution"

3. Microbial biotechnology: R&D

4. Microbial resources data management and research infrastructures

5. Public-private biotech sector linkages

6. Financial mechanisms

 

    POLICY:

1. The Convention on Biological Diversity

continue reading